HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

Clinical trial NCT01119066 · COMPLETED

Trial details

NCT number: NCT01119066
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myelogenous Leukemia Myelodysplastic Syndrome Multiple Myeloma

Start date: 2010-05-03
Primary completion: 2021-03-30
Enrollment: 422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.